RC 0315
Alternative Names: RC-0315Latest Information Update: 28 Mar 2024
At a glance
- Originator Remedy Cell
- Class Antifibrotics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Idiopathic pulmonary fibrosis